Stock Exchange
Novo Nordisk Shock: Shares Plummet After Promising Drug Trial Hits Snag!
Novo Nordisk, the pharmaceutical titan known for many groundbreaking health solutions, faced a turbulent market reaction recently. Despite the anticipation surrounding its next-generation weight loss drug, the company’s shares experienced a significant 5.5% nosedive. What went wrong for the stalwart that analysts often lauded for its innovative health